Investor
Data Collective IV GP, LLC
CIK 0001664974 · filed 2026-05-15 · SEC filing
13F book
$55.9M
Positions
4
2 new · 1 sold
Largest name
49.6%
Evolv Technologies Hldngs In
Est. mark
−$11.2M
Price effect on 2 names still held. Flow $8.6M.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Evolv Technologies Hldngs In | — | 4.59M | $27.8M | 49.6% | −$5.09M | Held |
| Recursion Pharmaceuticals In | — | 5.94M | $18.2M | 32.6% | −$6.06M | Held |
| Horizon Quantum Holdings Ltd | — | 915.2K | $8.04M | 14.4% | — | New |
| Definium Therape | DFTX | 100.3K | $1.9M | 3.4% | — | New |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.